For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230217:nRSQ2196Qa&default-theme=true
RNS Number : 2196Q Benchmark Holdings PLC 17 February 2023
RNS Reach
17 February 2023
Benchmark Holdings plc
("Benchmark", the Group, or the "Company")
Acquisition of remaining minority interest in Benchmark Genetics Iceland
Benchmark Holdings, the aquaculture biotechnology company, announces that it
has acquired the remaining 10.52% minority interest in its subsidiary
Benchmark Genetics Iceland. Enhanced by the recent construction of a new
incubation centre, Benchmark Genetics Iceland is core to the Company's ability
to supply highly specialist, biosecure salmon eggs to salmon producers to c.35
countries around the world, year-round. Benchmark Genetics Iceland represents
50% of the Group's salmon egg capacity.
Background
In December 2014 Benchmark acquired a 89.48% interest in Stofnfiskur,
subsequently rebranding it Benchmark Genetics Iceland and merging it with its
salmon genetics business in Norway. Since the acquisition, the business has
grown substantially, benefitting from Benchmark's leading market position,
investment and knowledge transfer within the Group.
Trond Williksen commented:
"Benchmark's genetics operations in Iceland have a 200m egg capacity and are
core to our ability to supply highly biosecure salmon eggs year round to
customers around the world. The acquisition of the remaining minority interest
is a natural step in delivering shareholder value through full ownership of
the success of our genetics business."
Rabobank acted as financial adviser to Benchmark in the transaction.
Enquiries
For further information, please contact:
Benchmark Holdings plc Tel: 020 3696 0630
Trond Williksen, CEO
Septima Maguire, CFO
Ivonne Cantu, Investor Relations
Numis (Broker and NOMAD) Tel: 020 7260 1000
James Black, Freddie Barnfield, Duncan Monteith
MHP Tel: 020 3128 8004
Katie Hunt, Reg Hoare, Veronica Farah benchmark@mhpgroup.com
About Benchmark
Benchmark is a market leading aquaculture biotechnology company. Benchmark's
mission is to drive sustainability in aquaculture by delivering products and
solutions in genetics, advanced nutrition and health which improve yield,
growth and animal health and welfare.
Through a global footprint in 26 countries and a broad portfolio of products
and solutions, Benchmark serves major aquaculture species - salmon, shrimp,
sea bass and bream and tilapia - in main aquaculture regions around the world.
Find out more at www.benchmarkplc.com (http://www.benchmarkplc.com)
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NRATFMBTMTBBTRJ